Related Experiment Video

Updated: Jul 4, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

Type 1 diabetes: increased height and weight gains in early childhood

Magnus Ljungkrantz1, Johnny Ludvigsson, Ulf Samuelsson

  • 1Department of Paediatrics, Blekingesjukhuset, Karlskrona, Sweden.

Pediatric Diabetes
|June 11, 2008
PubMed

Insights

Rapid childhood growth and increased body mass index (BMI) are risk factors for type 1 diabetes. This supports the accelerator/beta-cell stress hypothesis, linking weight gain to diabetes development.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Metabolic Disorders

Background:

  • The accelerator/beta-cell stress hypothesis proposes insulin resistance as a common factor in type 1 and type 2 diabetes.
  • Weight gain is considered a significant trigger for type 1 diabetes development.

Purpose of the Study:

  • To investigate the accelerator/beta-cell stress hypothesis by examining children's growth patterns before type 1 diabetes diagnosis.
  • To identify potential links between early-life weight and height gain and the risk of developing type 1 diabetes.

Main Methods:

  • A comparative study analyzing growth charts (n=316) of children diagnosed with type 1 diabetes (ages 0-16) against age- and sex-matched controls.
  • Growth data from birth up to the point of diagnosis was assessed.

Main Results:

  • Children diagnosed with type 1 diabetes exhibited more pronounced weight and height gain compared to controls.
  • Higher weight and body mass index (BMI) at age 5 were significant predictors of later type 1 diabetes risk.
  • Rapid weight gain between 3 months and 3 years was associated with earlier diagnosis (≤5 years), while accelerated height gain before age 5 was linked to diagnosis between 6-10 years.

Conclusions:

  • Accelerated growth in early childhood (before age 7) and elevated BMI are identified as risk factors for developing type 1 diabetes later in life.
  • The findings provide support for the accelerator/beta-cell stress hypothesis regarding the etiology of type 1 diabetes.
Abstract

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-1906:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...